TMCI

#3097
Treace Medical Concepts, Inc. - Common Stock
3.4 6 USD
+12.34%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
3.46
3.46
년간 변동
1.17
7.78
일일 변동
+12.34%
월간 변동
+95.48%
6달 변화
+18.49%
년간 변동율
-40.45%
이전 종가
3.0 8
Open
3.4 6
저가
3.4 6
High
3.4 6
양
60
전체 차트 열기 Full chart

Financials

개요 성명 통계
4분기 연간
  • Market Capitalization 224.46 M
  • Employee 450
  • Founded 2014
  • CEO N/A
  • Website www.treace.com
  • Headquarter Florida, United States
  • FIGI BBG00GQKR6M4
  • Industry 의료 기기
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
-2.63
주가매출액비율
0.73

Treace Medical Concepts, Inc. - Common Stock

Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions. In March 2021, Treace announced its intent to launch an initial public offering. Trading on the Nasdaq under the ticker symbol “TMCI”, Treace opened its IPO in April 2021.

뉴스